Skip to main content

Table 1 Overview of measurements per time point

From: (Cost)-effectiveness of a multi-component intervention for adults with epilepsy: study protocol of a Dutch randomized controlled trial (ZMILE study)

Outcomes patients

Instrument

Short term

T0

T1

T2

T3*

T4*

Demographic and clinical characteristics

-

-

X

-

-

-

-

Self-efficacy

Epilepsy Self-efficacy Scale – 33 items

ESES

X

X

X

X

X

General self-efficacy

Generic Self-efficacy Scale – 10 items

GSES

X

X

X

X

X

Adherence

MEMS Medication Adherence Scale

MARS 5

X

X

X

X

X

Seizure frequency

Questionnaire seizure frequency

-

X

X

X

X

X

Seizure severity

National Hospital Seizure Severity Scale

NHS3

X

X

X

X

X

Emotional functioning

Hospital Anxiety and Depression Scale

HADS

X

X

X

X

X

Quality of life

Quality Of Life in Epilepsy

QOLIE31P

X

X

X

X

X

Generic quality of life

EQ-5D-5L

X

X

X

X

X

Proactive coping

Utrecht Proactive Coping Competence

UPCC/PCI

X

X

X

X

X

Side effect

Side effects of Anti-epileptic Drugs

SIDAED

X

X

X

X

X

Healthcare resource use

Medical Cost Questionnaire

MCQ

X

X

X

X

X

Productivity Cost Questionnaire

PCQ

  1. T0 = baseline outcome assessments; T1 = Outcome assessments after 3 months; T2 = Outcome assessments after 6 months; T3 = Outcome assessments after 9 months; T4 = Outcome assessments after 12 months.
  2. *Outcome assessment applicable only for intervention group.